CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 56 enrolled
Drug / intervention
Naturally-sweetened orange juice +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03527277
NCT03527277N/ACompleted
CompareCT.gov

The Effects of Orange Juice Compared With Sugar-sweetened Beverage on Risk Factors and Metabolic Processes Associated With the Development of Cardiovascular Disease and Type 2 Diabetes

University of California, Davis·interventional·Posted May 17, 2018·Updated Nov 10, 2025

In Brief

A clinical study evaluating Naturally-sweetened orange juice and Sugar-sweetened beverage for Cardiovascular Risk Factor and 3 related conditions. Completed, enrolled 56 participants across 1 site.

Detailed Summary

The objectives of this proposal are to address the gaps in knowledge regarding the metabolic effects of consuming orange juice, the most frequently consumed fruit juice in this country, compared to sugar-sweetened beverage.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Risk Factor, Type2 Diabetes Mellitus, Insulin Sensitivity, Metabolic Syndrome
CountriesUnited States
CollaboratorsTouro University, California, National Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedMay 17, 2018
Enrollment StartJun 1, 2018
Primary CompletionMay 28, 2023
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 8.1 years ago

Interventions

Naturally-sweetened orange juiceother

Commercially-available ready-to-serve refrigerated orange juice

Sugar-sweetened beverageother

Sugar-sweetened water flavored with Kool-Aid (TM)